Исследование памяти Исследование речи, чтения и письма Исследование гнозиса Оценка праксиса
жүктеу/скачать 2,45 Mb.
|
6-когнитивные-нарушения
| Waegemans T, Wilsher CR, Danniau A. et al. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Dement Geriatr Disord. -2002. –V.13. –P.217-224.
Weinmann S., Roll S., Schwarzbach C. et al. Effects of Ginkgo biloba in dementia: systematic review and meta-analysis// BMC Geriatrics 2010, 10:14 Weintraub D, Rosenberg PB, Drye LT et al. Sertraline for the treatment of depression in Alzheimer disease: Week-24 outcomes. // Am J Geriatr Psychiatry2010;18:332–340. Wechsler D. A standardized memory scale for clinical use. J of Psychology. -1945. –V.19. –P. 87-95. Wechsler D. Manual for the Wechsler Adult Intelligence Scale. N.Y., 1955 Wilcock G, Mo¨bius HJ, Sto¨ffler A; MMM 500 Group. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). // Int Clin Psychopharmacol. 2002;17:297–305. Wilson R. S., Scherr P. A., Schneider J. A. et al. Relation of cognitive activity to risk of developing Alzheimer disease // Neurology, 2007; 69:1911–1920. Wilcock GK, Ballard CG, Cooper JA, Loft H. Memantine for agitation/ aggression and psychosis in moderately severe to severe Alzheimer’s disase: a pooled analysis of 3 studies. // J Clin Psychiatry. 2008;69:341–348. Winblad B, Poritis N. Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). //Int J Geriatr Psychiatry. 1999;14:135–146. жүктеу/скачать 2,45 Mb. Достарыңызбен бөлісу:
|